N. Kikuta

Safety, tolerability and efficacy of repeated intravenous infusions of KHK4083, a fully human anti-OX40 monoclonal antibody, in Japanese patients with moderate to severe atopic dermatitis.

H. Nakagawa, H. Iizuka, O. Nemoto, 2020, Journal of dermatological science.

Pharmacological profile and clinical efficacy of fully human anti-IL-17RA antibody Brodalumab (LUMICEF® Subcutaneous Injection 210 mg Syringe).

Yukiko Aono, T. Amano, N. Kikuta, 2016, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.